designed and synthesized a selective inhibitor of c-Fos/AP-1, termed T-5224, using three-dimensional (3D) pharmacophore modeling based on a crystal structure of the AP-1–DNA complex, and found that selective inhibition of c-Fos/AP-1 resolved disease in a mouse model of arthritis. This evidence concerns the gene FOS and Arthritis.